|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development costs, net | |||||
| General and administrative costs | |||||
| Professional fees | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Financial expenses | |||||
| Share in losses of affiliate | |||||
| Other income (Note 3d) | |||||
| Financial income (expenses), net | |||||
| Equity in losses from investment in affiliate | |||||
| Loss before income tax | |||||
| Tax income | |||||
| Net loss | |||||
| Net loss attributable to non-controlling interest | |||||
| Net loss attributable to the Company | |||||
| Other comprehensive loss | |||||
| Total comprehensive loss | |||||
| Comprehensive loss attributable to non-controlling interests | |||||
| Comprehensive loss attributable to the Company | |||||
| Basic loss per common stock | |||||
| Weighted average common stock outstanding | |||||
Loading...